Genetic alterations in pediatric high-grade astrocytomas

Area of Science:

• Pediatric Oncology
• Neuro-oncology
• Cancer Genetics

Background:

• Pediatric high-grade astrocytomas (HGA) are rare and their molecular characteristics are poorly understood.
• It remains unclear if pediatric HGA share genetic pathways with adult diffuse astrocytomas.
• Understanding these pathways is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the molecular properties of sporadic pediatric HGA.
• To compare the genetic profiles of pediatric HGA with those of adult astrocytomas.
• To identify potential therapeutic targets by analyzing key gene mutations and alterations.

Main Methods:

• Analysis of 24 primary sporadic pediatric HGA (11 anaplastic astrocytomas, 13 glioblastomas).
• Assessment of p53 and phosphatase and tensin homolog (PTEN) mutations.
• Evaluation of loss of heterozygosity (LOH) at 17p13, 9p21, and 10q23-25.
• Detection of epidermal growth factor receptor (EGFR) amplification and protein overexpression.
• Investigation of microsatellite instability (MSI) and replication error (RER+) phenotype.

Main Results:

• p53 mutations occurred in 38% of pediatric HGA, and 71% of brainstem tumors.
• PTEN mutations were found in 8% of cases; no EGFR amplification was observed.
• High frequencies of LOH were detected at 9p21 (83%) and 10q23-25 (78%).
• Four tumors exhibited MSI, with two showing a RER+ phenotype and concurrent LOH at 9p21 and 10q23-25.
• Inactivation of both PTEN and p53 alleles was observed in a significant subset of tumors.

Conclusions:

• Pediatric high-grade astrocytomas may develop through distinct genetic pathways compared to adult glioblastomas.
• Genomic instability, indicated by MSI and LOH, plays a role in a subset of these tumors.
• These findings highlight the need for pediatric-specific molecular profiling and therapeutic strategies.